PEHL MICHAEL F. 4
4 · IMMUNOMEDICS INC · Filed Dec 11, 2017
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
PEHL MICHAEL F.
DirectorPresident and CEO
Transactions
- Award
Stock Options (right to buy)
2017-12-07+750,000→ 750,000 totalExercise: $11.86Exp: 2024-12-07→ Common Stock, par value $0.01 per share (750,000 underlying) - Award
Stock Options (right to buy)
2017-12-07+1,500,000→ 1,500,000 totalExercise: $11.86Exp: 2024-12-07→ Common Stock, par value $0.01 per share (1,500,000 underlying)
Footnotes (3)
- [F1]The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter.
- [F2]The reporting person was granted performance-based vesting stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options will vest (i) as to 750,000 shares (a) 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter through the fourth anniversary of the date of grant (each date a "Vesting Date") and (b) subject to Immunomedics, Inc. common stock achieving a fair market value of $23.72 or higher based on the average closing price for the prior 15 consecutive trading days on such Vesting Date; and (ii) as to 750,000 shares (a) 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter through the fourth anniversary of the date of grant and (b) subject to Immunomedics, Inc. common stock achieving a fair market value of $35.58 or higher based on the average closing price for the prior 15 consecutive trading days on such Vesting Date.
- [F3]To the extent, the performance-based vesting criteria of the stock options is not attained on an applicable Vesting Date, to the extent such performance-based vesting criteria is subsequently attained the tranche of stock options may vest on the date such criteria is met.